📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Inhibition of tumour necrosis factor alpha in the R6/2 mouse model of Huntington's disease by etanercept treatment (2019)

First Author: Pido-Lopez J

Attributed to: Targeting the innate immune system in Huntington's disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-019-43627-3

PubMed Identifier: 31076648

Publication URI: http://europepmc.org/abstract/MED/31076648

Type: Journal Article/Review

Parent Publication: Scientific Reports

Issue: 1

ISSN: 2045-2322